OTCQB:VVCIF - Post by User
Comment by
Schaffhausenon Oct 05, 2020 7:24am
182 Views
Post# 31665667
RE:Vivo doing all the right things...but clearly a 2021 story
RE:Vivo doing all the right things...but clearly a 2021 story
I'm not excited by eu gmp licensing. Vivo is building its presence in Germany without supplying feedstocks from Canada; thats what Linneo deal is for. Any fledgling Germany sales won't have high margin but who cares, that is not the primary goal as they work to develop the market and build branding. When EU GMP comes to Napanee likely in 2021 that will help in 2022 and beyond if Vivo has success in building up German market in the meantime. The real prize for Vivo is simple...continue on their growth path...continue with the sixth consecutive quarter of revenue growth...continue to lead the concentrates markets...continue to control costs...continue to lead novel recreational product development...continue to use data analytics to define pharmaceutical products and marketing...continue to market high margin brands. Cheers, Schaff